Examination of Orbital Tissues in Murine Models of Graves' Disease Reveals Expression of UCP-1 and the TSHR in Retrobulbar Adipose Tissues
mune reaction is induced. This can be facilitated using a variety of techniques, such as introduction of the TSHR as a recombinant protein, of foreign cells expressing the receptor, or via genetic immunization with cDNA, or adenoviral constructs expressing the extracellular domain of the hTSHR or its A-subunit [ 8 -17 ] . Immunizations against the murine TSHR have failed to result in desired autoimmunity, due to the host organism's tolerance [ 18 ] . While thyroid autoimmunity and hyperthyroidism can be reliably induced using adenovirus encoding for the TSHR A-subunit [ 19 , 20 ] or through intramuscular electroporation of TSHR encoding plasmids [ 21 ] , orbital manifestations had been reported by only one group of investigators, describing infi ltration of orbital tissues by macrophages and lymphocytes [ 22 ] . The reported orbital manifestations could not be reproduced by other investigators [ 23 , 24 ] . Sporadic examination of extraocular muscles by other groups showed no evidence of eye muscle infl ammation or edema [ 14 , 16 ] . Additionally, the process of eye muscle Introduction ▼ Graves' disease (GD) is a systemic autoimmune disease, which is comprised of hyperthyroidism, orbitopathy, and, more rarely, dermopathy and acropachy [ 1 , 2 ] . Twenty-fi ve to 50 % of patients, suff ering from GD, show symptoms of orbital infl ammation [ 1 , 3 ] . Clinical symptoms of orbitopathy are due to infl ammation of orbital connective tissue, infl ammation, and fi brosis of the extraocular muscles and adipogenesis. Hyperthyroidism is caused by stimulating TSH receptor antibodies (TSAb). The receptor is also regarded as one of the major antigens in the orbit. Clinically, high TSAb concentrations are associated with a higher prevalence and more severe course of extra-thyroidal symptoms, especially orbitopathy [ 4 -7 ] . While there is no spontaneous animal model for GD, a number of induced mouse models have been described over the past decades. All of these models have in common that by immunization against the hTSHR or parts thereof an autoim- 
▼
Over the past decade a number of murine models of Graves' disease (GD) have been described. The full symptom complex, including typical orbital changes, however, could not yet be induced. In this report, we examined the infl uence of modifi ed immunization protocols on orbital pathology. C57BL/6 and BALB/c mice were immunized against the human TSH receptor (TSHR), using either a TSHR encoding plasmid or a TSHR A-subunit adenovirus. Prior to immunization with the TSHR plasmid, regulatory T cells were depleted in one group of each strain. TSHR-stimulating antibodies (TSAbs) were evaluated and orbits were stained immunohistochemically for F4/80, uncoupling protein-1 (UCP-1) and the TSHR. We found that after depletion of regulatory T cells, incidence of TSAb was increased in TSHR plasmid immunized C57BL/6 mice. Examination of early immunized mice showed no antibody production. However, a TSHR epitope-specifi c cellular immune response could be detected by tetrameranalyses. Adenoviral immunization lead to TSAb production in all but one animal. Analysis of F4/80 positive cells in retrobulbar fat revealed no signifi cant macrophage infi ltration in the orbits of immunized mice. Immunohistochemical staining shows co-localization of F4/80 positive cells, UCP-1 and the TSHR in retrobulbar fat. Though targets for TSHR autoimmunity could clearly be shown, immunization methods were not effi cient enough to cause clear signs of orbital infl ammation.
preparation was not described in detail. Since the process of removing extraocular muscles from the orbit, even if performed with the utmost care, may have led to tissue strain and also bleeding, artefact formation may not be excluded. The aim of our study was to establish a more refi ned technique to reliably examine mouse orbits without the risk of artefact induction and to examine the infl uence of modifi ed immunization protocols on orbital pathology.
Materials and Methods

▼
Mice and immunization protocols
For anatomic and histologic examination, female C57BL/6 and BALB/c mice, as well as C3H, A/J, FrBn, and NMRI (4-5 weeks old) were originally purchased from Harlan Laboratories (Rossdorf, Germany) and kept in a specifi c pathogen-free facility. Attempts to induce Graves' disease were performed on 6 groups of C57BL/6 and BALB/c mice, which were immunized using either TSHR cDNA or the AdTSHR289 construct. Mice of the same strains, sex, and age were used as controls. Immunization with AdT-SHR289 was performed in Nagasaki. A diff erent set of controls was used for mice that were raised in Essen and Nagasaki, respectively, to avoid infl uence of environmental factors. Experiences of 3 previously described animal models were combined in our approach as detailed in • ▶ Table 1 . Genetic immunization against the D633H activating mutant of the human TSHR, as described by Ho et al. [ 25 ] , was combined with depletion of CD25 + regulatory T-cells as described by Saitoh and Nagayama [ 17 ] . Prior to injection in the M. quadriceps femoris, 100 μg plasmid was adsorbed to an aluminum phosphate adjuvant (AdjuPhos, Brenntag Biosector, Frederiksund, Denmark) to facilitate stronger immune reactions [ 26 ] . Injection volumes per site were 50 μl. Immunization with the AdTSHR289 construct was performed as described previously [ 17 ] . To evaluate immunization, animals were sacrifi ced, blood was collected by cardiac puncture under anesthesia with 10 μl i.p./g (body weight) ketamine 2 %/xylazine 0.1 % (CEVA Tiergesundheit GmbH, Düsseldorf, Germany); thyroid and orbits were collected and prepared for histologic examination. Animals were kept under standard conditions and were fed regular chow (ssniff M-Z, ssniff Spezialdiäten GmbH, Germany). All procedures performed on mice in Essen were approved by the State Offi ce for Nature, Environment and Consumer Protection of North Rhine-Westphalia, Germany in accordance with §8 of the Animal Protection Act (Tierschutzgesetz) in the edition of 5/18/2006. All procedures performed on mice in Nagasaki were performed in accordance with the Guideline for Animal Experimentation of Nagasaki University with approval of the Institutional Animal Care and Use Committee. Two animals, one from the undepleted C57BL/6 and one from the depleted group had to be euthanized before examination, due to hydrocephalus and malformed teeth, respectively.
Plasmid and adenovirus preparation
The activating mutant D633H -a kind gift from Dr. Su-Chin Ho of SingHealth Research, Singapore -was introduced via PCR into the wild type full length sequence for the human TSHR as described previously [ 25 ] . Construction and purifi cation of adenovirus containing amino acid residues 1-289 of the human TSHR (TSHR-289-ad) has also been described previously [ 17 , 19 ] . The vector was provided by Drs. B. Rapoport and S. M. McLachlan (Cedars-Sinai Medical Center, University of California, Los Angeles, CA, USA). Adenovirus was propagated in and purifi ed by CsCl density gradient centrifugation [ 17 ] .
Antibody preparation
Rat anti-mouse CD25 was obtained through purifi cation of hybridoma supernatants [ 27 ] . Antibody functionality was tested through FACS analysis of CD4 + CD8 + CD25 + (FITC-conjugated anti-mouse CD4, PE-conjugated anti-mouse CD8, APC-conjugated anti-mouse CD25, BD Pharmingen, Heidelberg, Germany) mouse splenocyte population 4 days after i.p. injection.
Tetramer analysis
After exsanguination -but before perfusion fi xation -mice were splenectomized. Spleens were crushed and homogenized in unsupplemented DMEM. Splenocytes were isolated using Histopaque (Sigma-Aldrich, St. Gallen, Switzerland) according to a standardized protocol, resuspended and washed in DMEM, supplemented with 10 % FCS. Cells were then stored at − 80 °C so they could be analyzed simultaneously. For tetramer analysis, cells were thawed and resuspended in 100 μl MACS buff er (Miltenyi, Bergisch-Gladbach, Germany), supplemented with 50 μl FCS, 10 μl FCR blocking reagent (Miltenyi, Bergisch-Gladbach, Germany) and 4 μl tetramer (Glycotope Biotechnology, Heidelberg, Germany), followed by incubation on ice for 1 h. All TSHR tetramers and corresponding peptides were selected according to their calculated binding scores calculated with SYFPEITHI ( www.syfpeithi.de ), a database of more than 7 000 peptide sequences known to bind MHC class I and class II molecules. Binding scores of ≥ 15 were considered highly immunogenic (reviewed in [ 28 ] ). Based on the amino acid sequence of human TSHR, all tetramers (H2-Kb specifi c) had high binding scores between 22 and 24. The following PE-conjugated tetramers and corresponding epitopes were chosen: T1 [amino acid position (AA) 412-419]: MGYKFLRI, T2 (AA68-73): PSHAFSNL, T3 (AA93-100): ESHSFYNL. Anti-CD8 FITC was added to each of the samples besides anti-IgG1 FITC and PE and anti-CD45 FITC antibodies, which were used as a negative and positive control, respectively. For additional negative control the tetramer "SIINFEKL" was used, delivering only a positive signal for animals immunized with ovalbumin. Cells were analyzed on a FACS Calibur (BD Bioscience, San Jose, CA, USA) equipped with BD-CellQuest-Pro software.
TSAb measurements
Mice were exsanguinated by cardiac puncture under anesthesia with ketamine/xylazine. Whole blood was kept on ice and spun down at 6 000 RPM (Mikro 200R Hettich Centrifuges, Tuttlingen, Germany) for 15 min. After collection, serum was stored at Female 4-6 week old C57BL/6 and BALB/c mice were immunized 4 times in 2 week intervals against the D633H activating mutant of the human TSHR with and without depletion of CD25 + T-cells. Two additional groups of each strain were immunized against the A-Subunit of the human TSHR using a recombinant adenovirus (AdT-SHR289). Immunization of mice with AdTSHR289 was performed in Nagasaki − 80 °C until measurement of TSAbs was performed. TSAbs were measured as described by Morgenthaler et al. [ 29 ] . Thyroid stimulation index (SI) was calculated as:
Histology
Mice were anesthesized as described above. Perfusion fi xation was performed as previously described [ 30 ] . The orbit was removed completely, including adjacent bony structures, to leave its contents untouched. Orbital tissues were decalcifi ed in EDTA for 24 h. For HE staining single slides of paraffi n embedded tissue were rehydrated and stained with Meyers hemalum and eosin (Chroma 1B, Schmid GmbH, Münster, Germany) for 3 min each. Immunohistochemical visualization of macrophages was performed using rat-anti-mouse F4/80 (1:100, Abd Serotech, Oxford, UK). Uncoupling protein-1 (UCP-1) was stained using rabbit anti-mouse UCP- 
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software Inc., San Diego CA). Data was analyzed using the Kruskal-Wallis test; post-testing was conducted with Dunn's multiple comparison test. 
Results
▼
Anti-TSHR antibodies
Tetramer analysis
The low incidence of stimulating TSAbs in D633HTSHR immunized mice led us to perform tetramer analyses to detect specifi c TSHR immune reactions during the early phase of immunization. 
Histologic preparation of orbital tissues and target antigens
To exclude preparation artefacts we developed a technique of in toto preparation of orbits. In • ▶ Fig. 2 , UCP-1 staining of slices of several mice strains is displayed. Clear anatomical landmarks can be recognized. The centrally located optic nerve is surrounded by orbital fat and embedded in the muscle cone. UCP-1 as marker for brown adipose tissue was concentrated in the smaller vacuoles of adipose tissue ( • ▶ Fig. 2 , arrows) . The target antigen TSHR could also be clearly detected in the orbital fat of all investigated strains ( • ▶ Fig. 3 ). 
Infl ammatory cells in the orbital tissues
Discussion
▼
In the present study, we describe a technique to reliably examine mouse orbits. The new technique was applied to examine the infl uence of modifi ed immunization protocols against the hTSHR to induce Graves' orbitopathy like changes in the murine orbit.
Modifi ed immunization protocols lead to induction of TSAb tit- ers but did not result in signifi cant infl ammatory and proliferative orbital changes. Many et al. were the fi rst to report signs of orbital involvement in a mouse model of GD [ 22 ] . Attempts by members of the same group to re-establish this model in Cardiff failed, water imported even with drinking water, imported from Brussels, as well as identical chow and bedding and mice obtained from the same distributor. In the end it was concluded that diff erences in microbial fl ora had rendered the animals resistant to induced GD [ 23 , 32 ] . The authors described deposits of an amorphous material or fi brous tissue and adipose tissue infi ltrating the extraocular muscles, often in association with mast cells and macrophages. However, the described orbital changes were diffi cult to quantify. Our technique of in toto removal of the mouse orbit allows signifi cantly improved orbital preparation. Clear anatomical landmarks are visible. The presented technique will increase the sensitivity of detection because artefacts can be easily revealed. We further examined the occurrence of brown adipose tissue (specifi c marker UCP-1) in murine orbits. Brown adipose tissue is involved in thermogenesis and expresses high levels of the TSHR [ 33 ] -the target antigen in Graves' orbitopathy. UCP-1 has been detected in human orbital preadipocytes [ 34 ] , which are involved in pathologically increased adipogenesis in GO. Our immunohistological fi ndings revealed brown adipose tissue in all examined mouse strains and abundant expression of TSHR. We did not examine the eff ect of immunization on UCP-1 staining. We did also not quantify the UCP-1 and TSHR content in diff erent strains since both receptors were abundantly expressed. We selected BALB/c and C57BL/6 due to the fact that those strains were most often used to successfully establish mouse models in GD and various knock outs of these strains are available. In most studies orbital changes have not been examined systematically [ 8 -17 , 19 , 20 , 25 ] and groups who did examine the orbit had not applied our approach of full orbital removal, so subtle changes in the orbit might have been overlooked [ 14 , 16 ] . We therefore examined mouse orbits after immunization with a plasmid coding for the TSHR activating mutant D633H or a TSHR A-subunit adenovirus, which are techniques that have reliably induced thyroid autoimmunity before [ 17 , 25 ] . The prevalence of TSAb varies slightly throughout the literature. Immunization of Swiss outbred mice using the plasmid encoding for the activating mutant D633H ended up with 90 % prevalence of stimulating TSAb [ 25 ] . Although a similar immunization protocol was used, we detected the stimulating TSAb only in 2/9 C57BL/6 mice and in none of tvhe BALB/c mice. In contrast, BALB/c developed TSAb when immunized by in vivo electroporation with the TSHR A-subunit plasmid alone or in combination with an IGF-1Rα encoding plasmid [ 35 ] . Some of those mice also developed pathological changes in thyroid (42 % vs. 33 %) and Fig. 3 Immunohistochemical visualization of macrophages, brown fat and TSHR in murine retrobulbar fat. Orbits of C57/BL/6 and BALB/c mice were subjected to immunohistochemistry. Macrophages were stained using a F4/80 antibody. Arrows indicate macrophages in the orbital fat. UCP-1 antibodies were used to visualize brown fat (UCP-1) and TSHR was stained as described in the methods section. Images were captured at 200 × magnifi cation. Inserted images were captured at 400 × magnifi cation. Bars represent 100 μm.
orbit (both groups 83 %). Histological analysis of the orbital tissues revealed moderate connective tissue fi brosis and deposition of Masson's trichrome staining material [ 35 ] . Depletion of CD25 + regulatory T cells with an anti-CD25 antibody leads to a signifi cantly higher incidence of stimulating antibodies in C57BL/6 and to more marked hyperthyroidism in BALB/c mice after adenoviral immunization [ 17 ] . Likewise, when we used the D633HTSHR plasmid in combination with CD25 depletion, a higher percentage of C57BL/6 mice (4/9) showed TSAb. However, none of the BALB/c mice were TSAb positive. In contrast, regardless of strain, almost all AdTSHR289 immunized mice developed TSAb (6/6 C57BL/6 and 5/6 of the BALB/c mice). This confi rms the results of Saitoh et al. [ 17 ] who found that C57BL/6 and BALB/c developed TSAb when immunized with AdTSHR289, but only BALB/c mice develop hyperthyroidism. Depletion of CD25 rendered some C57BL/6 mice susceptible to hyperthyroidism, which also developed extremely high TSAb activities [ 17 ] . Plasmid or adenoviral immunization with the TSHR A-subunit induces TSAb in C57BL/6 and BALB/c mice, whereas immunization with the D633HTSHR plasmid was less effi cient. Although mice immunized with the D633HTSHR plasmid alone did not develop TSAb within the fi rst weeks after immunization, among CD8 + splenocytes there was a signifi cant portion of specifi c anti-TSHR reacting T-cells. The D633H mutant is more intensely expressed on the cell surface than other gain of function mutants [ 36 ] , which allows antigen recognition by the immune system. However, despite the TSHR epitope-specifi c cellular immune response, humoral immunity could not be induced at all with the shorter immunization protocols. Nevertheless, it is noteworthy that TSHR specifi c CD8 + T cells were detected after immunization with the D633HTSHR plasmid, indicating for the fi rst time the participation of target specifi c cellular immune response in a murine model of Graves. We did not detect signifi cant infi ltration of orbital tissues with macrophages or lymphocytes, nor did we see changes of the extracellular matrix in any of the immunized animals. The most obvious explanation, according to recently published literature, seems to be the diffi culty to break tolerance to the TSHR and possible cofactors, which are necessary to induce orbitopathy. Recently, Nakahara et al. [ 37 ] described an elegant method to induce genuine TSHR autoimmunity in mice: Splenocytes from TSHR knockout BALB/c mice, which had been immunized with adenovirus, expressing the mTSHR A-subunit, were transferred into female athymic mice. Anti-TSHR autoantibodies were detected in approximately 50 % of recipient mice 4 weeks after adoptive transfer of splenocytes. Our group had the opportunity to examine the orbits of 9 of those mice, using our new method. In 2 of those mice we detected signifi cantly increased numbers of infi ltrating macrophages in both, the adipose tissues and the interstitium of muscle tissues. This clearly indicates a major role of the TSHR in the pathogenesis of Graves' orbitopathy and hints that more effi cient ways to overcome tolerance to the TSHR are necessary to induce orbital changes.
In conclusion, we have established a reliable technique to study manifestations of orbitopathy in mouse models of Graves' disease. We showed that common immunization protocols lead to production of TSAb, but do not necessarily result in signifi cant pathological changes in the orbit of C57BL/6 or BALB/c mice. It appears that either immunization against the TSHR A subunit and/or IGF1R by in vivo electroporation [ 35 ] , or adoptive transfer of primed splenocytes from TSHR knockout mice [ 37 ] are necessary to evoke the full spectrum of Graves' disease in mice. Yet even in those animals, orbital changes were still subtle, suggesting that further modifi cations will be necessary to increase disease severity, particularly with regard to orbital pathology.
